| Product Code: ETC10600673 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Fiji continued to import human insulin drugs and delivery devices primarily from top exporters such as New Zealand, USA, Australia, India, and Taiwan, Province of China. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained very high, indicating a competitive market dominated by a few key players. The compound annual growth rate (CAGR) for the period 2020-2024 was notably negative at -57.08%, with a further decline in growth rate from 2023 to 2024 at -57.1%. This suggests a challenging environment for the import market of human insulin products in Fiji.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Human Insulin Drugs and Delivery Devices Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Human Insulin Drugs and Delivery Devices Market - Industry Life Cycle |
3.4 Fiji Human Insulin Drugs and Delivery Devices Market - Porter's Five Forces |
3.5 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Insulin Type, 2021 & 2031F |
3.6 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Delivery Device, 2021 & 2031F |
3.7 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.8 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Patient Demographic, 2021 & 2031F |
3.9 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Treatment Goal, 2021 & 2031F |
4 Fiji Human Insulin Drugs and Delivery Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Fiji Human Insulin Drugs and Delivery Devices Market Trends |
6 Fiji Human Insulin Drugs and Delivery Devices Market, By Types |
6.1 Fiji Human Insulin Drugs and Delivery Devices Market, By Insulin Type |
6.1.1 Overview and Analysis |
6.1.2 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Type, 2021 - 2031F |
6.1.3 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Rapid-Acting Insulin, 2021 - 2031F |
6.1.4 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Long-Acting Insulin, 2021 - 2031F |
6.1.5 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Pre-mixed Insulin, 2021 - 2031F |
6.1.6 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Glargine, 2021 - 2031F |
6.2 Fiji Human Insulin Drugs and Delivery Devices Market, By Delivery Device |
6.2.1 Overview and Analysis |
6.2.2 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Pens, 2021 - 2031F |
6.2.3 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Pumps, 2021 - 2031F |
6.2.4 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Syringes, 2021 - 2031F |
6.2.5 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Pumps/Pens, 2021 - 2031F |
6.3 Fiji Human Insulin Drugs and Delivery Devices Market, By Formulation Type |
6.3.1 Overview and Analysis |
6.3.2 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.3 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.4 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.5 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4 Fiji Human Insulin Drugs and Delivery Devices Market, By Patient Demographic |
6.4.1 Overview and Analysis |
6.4.2 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Type 1 Diabetes, 2021 - 2031F |
6.4.3 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Type 2 Diabetes, 2021 - 2031F |
6.4.4 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Children, Adults, 2021 - 2031F |
6.4.5 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Elderly Population, 2021 - 2031F |
6.5 Fiji Human Insulin Drugs and Delivery Devices Market, By Treatment Goal |
6.5.1 Overview and Analysis |
6.5.2 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Blood Sugar Control, 2021 - 2031F |
6.5.3 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Long-term Glycemic Control, 2021 - 2031F |
6.5.4 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Immediate Blood Sugar Regulation, 2021 - 2031F |
6.5.5 Fiji Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Overnight Glucose Control, 2021 - 2031F |
7 Fiji Human Insulin Drugs and Delivery Devices Market Import-Export Trade Statistics |
7.1 Fiji Human Insulin Drugs and Delivery Devices Market Export to Major Countries |
7.2 Fiji Human Insulin Drugs and Delivery Devices Market Imports from Major Countries |
8 Fiji Human Insulin Drugs and Delivery Devices Market Key Performance Indicators |
9 Fiji Human Insulin Drugs and Delivery Devices Market - Opportunity Assessment |
9.1 Fiji Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Insulin Type, 2021 & 2031F |
9.2 Fiji Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Delivery Device, 2021 & 2031F |
9.3 Fiji Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.4 Fiji Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Patient Demographic, 2021 & 2031F |
9.5 Fiji Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Treatment Goal, 2021 & 2031F |
10 Fiji Human Insulin Drugs and Delivery Devices Market - Competitive Landscape |
10.1 Fiji Human Insulin Drugs and Delivery Devices Market Revenue Share, By Companies, 2024 |
10.2 Fiji Human Insulin Drugs and Delivery Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |